Financial Data and Key Metrics Changes - Total revenue for Q4 2025 was $373.1 million, a 25.6% increase from $297.1 million in Q4 2024 [5] - Adjusted earnings per share for Q4 2025 was $1.77, up 28.3% from $1.38 in Q4 2024 [6] - Adjusted EBITDA for Q4 2025 was $50.3 million, a 33.3% increase from $37.8 million in Q4 2024 [8] - Total revenue for 2025 was approximately $1.4 billion, a 23.2% increase from approximately $1.1 billion in 2024 [7] - Adjusted EBITDA for 2025 was $180 million, compared to $140.3 million in 2024, marking a 28.3% increase [8] Business Line Data and Key Metrics Changes - Personal Care Services revenue was $284.1 million, accounting for 76.5% of total revenue in Q4 2025 [22] - Hospice care revenue was $70 million, representing 18.9% of total revenue [23] - Home Health revenue was $17.1 million, making up 4.6% of total revenue [23] - Same-store revenue growth for Personal Care was 6.3% compared to Q4 2024 [11] - Hospice same-store revenue increased by 16% compared to Q4 2024 [12] Market Data and Key Metrics Changes - Texas and Illinois have recently increased rates for Personal Care Services, with Texas seeing a 9.9% increase effective September 1, 2025, and Illinois a 3.9% increase effective January 1, 2026 [9][18] - The average daily census for Hospice increased to 3,885 in Q4 2025, up from 3,472 in the same period last year, an increase of 11.9% [13] Company Strategy and Development Direction - The company aims to create geographic density and scale while focusing on the full continuum of Home Care [8] - The strategy includes pursuing acquisitions that complement organic growth and align with the company's goals [31] - The company is optimistic about the potential repeal of the 80/20 provision of the Medicaid Access Rule, which could positively impact the industry [10][81] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the value proposition of Personal Care Services and the company's ability to be a cost-effective partner for states and managed Medicaid payers [9] - The company anticipates continued growth opportunities in home-based care due to heightened awareness of its value [16] - Management noted stable hiring trends and a positive outlook for the labor market, with 101 hires per business day in Q4 2025 [10][43] Other Important Information - Cash flow from operations for Q4 2025 was $18.8 million, with cash on hand of approximately $81.6 million [8][30] - The company ended Q4 2025 with bank debt of $124.3 million, resulting in a net leverage of under 1x adjusted EBITDA [8] Q&A Session Summary Question: Rate backdrop in states like New Mexico and Tennessee - Management indicated a potential 4% to 5% rate increase in New Mexico is awaiting the governor's signature, which could benefit the company in the latter half of the year [34][35] Question: Margin flow-through from New Mexico - Management noted that while there isn't a mandatory pass-through rule in New Mexico, some portion of the rate increase will likely be passed through to caregivers [41] Question: Hiring trends and caregiver retention - Management reported stable hiring trends and good progress in hiring, with no significant difficulties noted [44] Question: Acquisition pipeline and opportunities - Management is optimistic about more acquisition opportunities in 2026, focusing on deals that create density in existing markets [47][48] Question: Impact of fraud and abuse focus on business growth - Management views the focus on fraud and abuse as an opportunity for growth, as smaller players may struggle to comply with regulations [61] Question: Update on Addus Connect app and its impact - Management reported positive momentum in service percentage due to the app, with ongoing rollout in New Mexico and Texas [64][65] Question: Home Health and Hospice bridging program - Management highlighted ongoing focus on the bridging program, with positive results expected as they continue to drive growth in key markets [88][92]

Market Overview - The Geriatric Care Devices Market was valued at USD 14.80 billion in 2025 and is projected to reach USD 26.83 billion by 2033, growing at a CAGR of 7.74% from 2026 to 2033 [1][16]. Growth Drivers - The growth of the geriatric care devices market is primarily driven by the rapidly aging global population, rising life expectancy, and increasing prevalence of age-related chronic conditions such as mobility impairments, hearing loss, cardiovascular diseases, and cognitive disorders [2]. - The shift toward home-based care and assisted living facilities is further supporting demand, as healthcare systems seek cost-effective alternatives to long-term hospital stays [4]. U.S. Market Analysis - The U.S. geriatric care devices market was valued at USD 3.82 billion in 2025 and is projected to reach USD 6.75 billion by 2033, expanding at a CAGR of 7.42% [5]. - Growth in the U.S. is supported by a rapidly expanding elderly population, well-established home healthcare infrastructure, and early adoption of technologically advanced care solutions [6]. Product Segmentation - Mobility Aids captured the largest market share of 32.45% in 2025, driven by the growing elderly population and increasing incidence of mobility-limiting conditions [8]. - Monitoring Devices are projected to grow at the fastest CAGR of 9.12%, supported by rising adoption of wearable health trackers and remote monitoring technologies [8]. Application Segmentation - Fall Prevention & Mobility accounted for the highest application share of 34.20% in 2025, primarily due to the high incidence of fall-related injuries among the elderly [9]. - Elderly Monitoring is expected to expand at the fastest CAGR of 9.05%, driven by the rising need for real-time health monitoring and chronic disease management [9]. End-User Segmentation - Hospitals & Clinics held the largest end-user share of 37.50% in 2025, supported by higher patient inflow and advanced diagnostic infrastructure [10]. - Home Care Settings are anticipated to grow at the fastest CAGR of 8.90%, driven by the shift toward home-based care models [10]. Distribution Channel Analysis - Direct Sales dominated the distribution landscape with a market share of 42.30% in 2025, as hospitals and institutional buyers prefer direct procurement [11]. - Online Platforms are projected to grow at the fastest CAGR of 9.25%, fueled by increasing digital adoption and wider product availability [11]. Regional Insights - North America contributed to more than 35.25% of the global geriatric care devices market revenue in 2025, with significant installations of mobility aids and monitoring devices [12]. - The Asia Pacific geriatric care devices market is estimated to register a CAGR of 8.84%, driven by increasing integration of smart and IoT-enabled solutions [13]. Major Players - Key players in the geriatric care devices market include Cardinal Health, Invacare Corporation, Medline Industries, and Sonova Holding AG among others [14].

Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $697 million, up from just under $687 million in Q3 2024, with a year-to-date revenue of nearly $2.1 billion, reflecting a 3.4% increase [14][15][18] - Adjusted EBITDA for Q3 2025 was $92 million, down from $108 million in Q3 2024, impacted by a one-time revenue benefit from the previous year [16][18] - Adjusted net income per share was $0.25 for Q3 2025, compared to $0.36 in Q3 2024, while year-to-date adjusted net income per share increased to $0.80 from $0.64 [18] Business Line Data and Key Metrics Changes - Year-over-year growth was noted in sleep therapy, ostomy, and urology categories, while diabetes showed flat performance compared to Q3 2024 but improved from Q2 2025 [15][16] - The company is focusing on improving therapy adherence and expanding customer capture across its ecosystem [15] Market Data and Key Metrics Changes - The company is positioned to benefit from the growing prevalence of chronic conditions such as diabetes and sleep apnea, with over 37 million diagnosed with diabetes and an estimated 85 million adults affected by obstructive sleep apnea in the U.S. [8][9] Company Strategy and Development Direction - The company announced a definitive agreement to sell its Products and Healthcare Services segment to Platinum Equity, allowing it to focus on its Patient Direct business and home-based care [5][6] - Future investments will prioritize technology and automation to enhance patient experience and operational efficiency [9][11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the home-based care business and the potential for growth following the divestiture, emphasizing a unified strategic focus [11][22] - The company anticipates a strong 2026, despite a significant customer loss, and plans to manage operational costs and improve cash flow [27][30] Other Important Information - The company expects to incur approximately $40 million in annualized stranded costs from the divestiture [18] - As of September 30, net debt was $2.1 billion, with expectations for slight reduction by year-end [19][20] Q&A Session Summary Question: Durability of trends going into 2026 and selling into the Optum channel - Management indicated that the Optum channel is new and expected to create more opportunities, with guidance for 2026 to be provided closer to year-end [26][27] Question: Outlook for 2026 and free cash flow trends - Management expects decent top-line growth and margin improvement in 2026, with free cash flow trends anticipated to remain stable despite some one-off costs [30][32] Question: Details on preferred provider agreements and filling the Kaiser contract loss - Management noted that it would take less revenue growth to cover the loss of the Kaiser contract due to its low margin nature, and emphasized the importance of preferred provider agreements [37][39] Question: Clarification on cash flow and balance sheet issues - Management explained that cash flow challenges were related to startup costs of a new kitting facility and over-acquired inventory, which are expected to normalize over time [40][42]